Why the study?
Recurrent stroke is a major cause of death, and introducing a stroke prevention education package to improve lifestyle behavioral factors could reduce vascular events.
Does a stroke prevention education package reduce recurrent strokes, myocardial infarction, and death in patients with stroke?
Does a stroke prevention education package reduce recurrent strokes, myocardial infarction, and death in patients with stroke?
This paper outlines the prespecified statistical analysis plan for the SPRINT INDIA trial to evaluate a stroke prevention education package.
Sets rigorous analysis framework for SPRINT INDIA RCT; extends transparency standards for stroke prevention trials.
Background: Recurrent stroke is one of the major causes of death in stroke patients. Introducing stroke prevention education package to improve the lifestyle behavioral factors could reduce the vascular events. The Secondary Prevention by Structured Semi-Interactive Stroke Prevention Package (SPRINT) study in India aims to assess the role of a stroke prevention education package to reduce recurrent strokes, myocardial infarction, and death in patients with stroke. The objective is to formulate the detailed statistical analysis plan for the SPRINT India prior to trial unblinding. Methods: The plan was developed by trial statisticians with the help of principal investigator and management team of the SPRINT study. The chosen primary and secondary outcome measures and knowledge of critical baseline data were used to construct the statistical analysis plan. All collected data will be thoroughly reviewed. Patient baseline characteristics will be summarized with relevant descriptive statistics. The findings are planned and explained for the most appropriate statistical comparison between the groups. Results: The final statistical analysis plan corresponds to established criteria and will allow for transparent and efficient reporting. Conclusions: The SPRINT trial statistical analysis plan is developed in order to avoid analysis bias arising from prior knowledge of findings and to explicitly summarize prespecified analyses.
No takes yet. Share an insight, caveat, or question.
Khatter et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: